AAAAI VJC logo

Virtual Journal Club Online: September 12, 2018

The Virtual Journal Club is a one hour live webinar open to all AAAAI members that focuses on the newest clinically relevant content published in JACI: In Practice. The presenters reviewed research relevant to your allergy/immunology practice in an interactive format. This is a recording of that webinar, which will be available for one year.

The September 12, 2018 webinar focused on two journal articles as follows (click the Program tab to download the PDFs):

N Andrasi MD, et. al. Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema, July–August, 2018, Volume 6, Issue 4, Pages 1205–1208.

Discussion Leader: Kevin D. Lindgren, MD, Rush University Medical Center/Rush Oak Park Hospital, Oak Park, IL

Mentor: David P. Huston, MD FAAAAI, Texas A&M Health Sciences Center College of Medicine, Houston, TX

M Ferrer MD, et al. Predicting Chronic Spontaneous Urticaria Symptom Return After Omalizumab Treatment Discontinuation: Exploratory Analysis, July–August, 2018, Volume 6, Issue 4, Pages 1191–1197.e5.

Discussion Leader: Stephanie L. Logsdon, MD, Cincinnati Children's Hospital, Cincinnati, OH

Mentor: Sarbjit Singh "Romi" Saini, MD FAAAAI, Johns Hopkins Allergy Asthma Center, Baltimore, MD


Target Audience

  • Allergist/Immunologists
  • Fellows-in-Training

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Contrast the clinical manifestations of idiopathic nonhistaminergic acquired angioedema, hereditary angioedema with C1-inhibitor deficiency, and hereditary angioedema of unknown origin
  • Identify variables that predict the probability of rapid symptom return following discontinuation of omalizumab for chronic spontaneous urticaria
Summary
Available credit: 
  • 1.00 Attendance
    Attendance credit.
  • 1.00 CME
    CME credit.
Course opens: 
09/14/2018
Course expires: 
09/13/2019
Cost:
$0.00
Rating: 
0
N Andrasi MD, et. al. Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema, July–August, 2018, Volume 6, Issue 4, Pages 1205–1208.

Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema.pdf

M Ferrer MD, et al. Predicting Chronic Spontaneous Urticaria Symptom Return After Omalizumab Treatment Discontinuation: Exploratory Analysis, July–August, 2018, Volume 6, Issue 4, Pages 1191–1197.e5.

Predicting Chronic Spontaneous Urticaria Symptom Return After Omalizumab Treatment Discontinuation-Exploratory Analysis.pdf

Planning Committee
Faith Huang, MD
South California Permanente Medical Group, Downey, CA
Relevant relationships: None

Amber Patterson, MD
Blanchard Valley Medical Associates, Findlay, OH
Relevant relationships: None

Michael Schatz, MD MS FAAAAI
Kaiser Permanente Medical Center, San Diego, CA
Relevant relationships: None

Jonathan Tam, MD
Children's Hospital Los Angeles, Los Angeles, CA
Relevant relationships: None

Faculty
David P. Huston, MD FAAAAI
Texas A&M Health Sciences Center College of Medicine, Houston, TX
Relevant relationships: None

Kevin D. Lindgren, MD
Rush University Medical Center/Rush Oak Park Hospital, Oak Park, IL
Relevant relationships: None

Stephanie L. Logsdon, MD
Cincinnati Children's Hospital, Cincinnati, OH
Relevant relationships: None

Sarbjit Singh "Romi" Saini, MD FAAAAI
Johns Hopkins Allergy Asthma Center, Baltimore, MD
Relevant relationships: Genentech (consultant: urticaria)

Content Reviewers
Shirley Joo, MD
Allergy Care Specialists, LLC, St. Louis, MO
Relevant relationships: None

Kasey Strothman, MD
Nationwide Children’s Hospital, Columbus, OH
Relevant relationships: None

AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters

  • Employment: Name of employer and job title.
  • Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
  • Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.

Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on September 13, 2019. Requests to claim credit on or after September 14, 2019 will be denied.

AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.

Questions
Activity-related questions should be directed to John Augustyniak and jaugustyniak@aaaai.org.

Registration and credit claiming questions should be directed to cme@aaaai.org.

Available Credit

  • 1.00 Attendance
    Attendance credit.
  • 1.00 CME
    CME credit.

Accreditation Period

Course opens: 
09/14/2018
Course expires: 
09/13/2019

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.